Gemstone Biotherapeutics LLC is a pre-clinical research and development initiative. Founded by George Davis in 2013, Gemstone Biotherapeutics is backed by investors that include Gamma3, Maryland Momentum Fund, and National Science Foundation and is headquartered in Baltimore.